{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T13:25:02Z","timestamp":1786886702070,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KE 2026\/3-1"],"award-info":[{"award-number":["KE 2026\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cyto.2026.157137","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:58:34Z","timestamp":1773633514000},"page":"157137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Presence of recombinant interleukin 1 receptor antagonist distorts selective analyte detection in a commercial multiplex assay"],"prefix":"10.1016","volume":"202","author":[{"given":"E.L.","family":"Verweyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2026.157137_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jri.2005.03.005","article-title":"Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants","volume":"66","author":"Dupont","year":"2005","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2026.157137_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","article-title":"Multiplex bead Array assays: performance evaluation and comparison of sensitivity to ELISA","volume":"38","author":"Elshal","year":"2006","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.cyto.2026.157137_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12865-016-0182-8","article-title":"Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells","volume":"17","author":"Surenaud","year":"2016","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157137_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","article-title":"Validation and comparison of two multiplex technologies, Luminex and mesoscale discovery, for human cytokine profiling","volume":"340","author":"Chowdhury","year":"2009","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.cyto.2026.157137_bb0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ymeth.2005.11.008","article-title":"Solid-phase and bead-based cytokine immunoassay: a comparison","volume":"38","author":"de Jager","year":"2006","journal-title":"Methods"},{"issue":"12","key":"10.1016\/j.cyto.2026.157137_bb0030","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.4049\/jimmunol.2000017","article-title":"A novel utility to correct for plate\/batch\/lot and nonspecific binding artifacts in Luminex data","volume":"204","author":"Maecker","year":"2020","journal-title":"J. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2026.157137_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cyto.2006.12.002","article-title":"Interference in microsphere flow cytometric multiplexed immunoassays for human cytokine estimation","volume":"36","author":"Phillips","year":"2006","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.cyto.2026.157137_bb0040","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1002\/jps.22700","article-title":"The impact of decreased bead count to determine concentrations of amyloid beta1-42, total-tau, and phosphorylated-tau181 in human cerebrospinal fluid using xMAP technology","volume":"100","author":"Bjornstal","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.cyto.2026.157137_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution","volume":"70","author":"Zachary","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2026.157137_bb0050","first-page":"22","article-title":"Clash of the cytokine titans: Counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses, in Cellular & Molecular Immunology","author":"Mayer-Barber","year":"2016","journal-title":"Nature Publishing Group"},{"key":"10.1016\/j.cyto.2026.157137_bb0055","series-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial), in Annals of the Rheumatic Diseases","first-page":"747","author":"Quartier","year":"2011"},{"issue":"5","key":"10.1016\/j.cyto.2026.157137_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.201903-0659OC","article-title":"Synergistic Signaling of TLR and IFNalpha\/beta facilitates escape of IL-18 expression from endotoxin tolerance","volume":"201","author":"Verweyen","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2026.157137_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100630","article-title":"A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling","volume":"296","author":"Li","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2026.157137_bb0070","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3389\/fimmu.2019.02508","article-title":"Leukocyte-released mediators in response to both bacterial and fungal infections trigger IFN pathways, independent of IL-1 and TNF-alpha, in endothelial cells","volume":"10","author":"Le","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2026.157137_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059327","article-title":"Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome","volume":"8","author":"Launay","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cyto.2026.157137_bb0080","series-title":"Interleukin-18 in health and disease, in Int. J. Mol. Sci","first-page":"649","author":"Yasuda","year":"2019"},{"issue":"4","key":"10.1016\/j.cyto.2026.157137_bb0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cts.12622","article-title":"Pharmacokinetics of anakinra in subjects of heavier vs","volume":"12","author":"Yang","year":"2019","journal-title":"Lighter Body Weights. Clin Transl Sci"},{"key":"10.1016\/j.cyto.2026.157137_bb0090","article-title":"Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cyto.2026.157137_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","article-title":"IL-1 receptor 2 (IL-1R2) and its role in immune regulation","volume":"32","author":"Peters","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cyto.2026.157137_bb0100","first-page":"99","article-title":"Host-directed therapy of Tuberculosis based on interleukin-1 and type I interferon crosstalk, in Nature","author":"Mayer-Barber","year":"2014","journal-title":"Nature Publishing Group"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:37:53Z","timestamp":1786883873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S1043466626000323"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157137","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presence of recombinant interleukin 1 receptor antagonist distorts selective analyte detection in a commercial multiplex assay","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"157137"}}